Deferoxamine mesylate
- Product NDC
- 60505-6237
- 11-digit product format
- 605056237
- Labeler code
- 60505
- Product ID
- 60505-6237_afafa387-54f4-e492-fea1-1872742d6674
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Deferoxamine mesylate
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Apotex Corp.
- Application
- ANDA207384
- Marketing category
- ANDA
- Marketing start
- 2021-11-05
- Substance
- DEFEROXAMINE MESYLATE
- Active strength
- 2 g/1
- Pharmacologic classes
- Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Deferoxamine mesylate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEFEROXAMINE MESYLATE | 2 g/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | V9TKO7EO6K |
| Rxcui | 1731345, 1731350 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60505-6237-6 | Deferoxamine mesylate | 4 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 4 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-6237 | DEFEROXAMINE MESYLATE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APOTEX CORP.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240926_c99553fb-3fae-b88a-6c2c-efa7520197f9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-6237-6 | 60505623706 | 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6) | 2021-11-05 | 0000-00-00 | No | No | Current |